Telesis Bio Inc. TBIO
0.00
(0.01)
(100.00%)
as of 25 Sep
- Market cap
- $5.3M
- P/E
- 0.0×
Follow TBIO
Growth Flags
show if company had growth for consecutive years
| Sep '24 | Jun '24 | Mar '24 | Dec '23 | Older periods | |
|---|---|---|---|---|---|
| 1,013.88% | (1,405.45%) | (332.08%) | (209.49%) |
+8 more TTM periods Free account |
|
| (73.87%) | (62.02%) | (61.81%) | (64.60%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(858.27%) | (449.42%) | (199.13%) | (172.23%) | |
Average Days of Receivables |
27.67 | 25.39 | 44.41 | 71.78 | |
Free Cash Flow per Share |
(13.45) | (13.17) | (17.20) | (22.07) | |
Free Cash Flow |
(23.85) | (22.78) | (28.73) | (36.63) | |
Capital Expenditures |
(0.98) | (0.99) | (2.00) | (1.96) | |
Piotroski F-Score |
1.00 | 2.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
139.65% | 450.06% | (208.75%) | (138.74%) | |
Accounts Receivable Turnover |
5.03 | 4.01 | 5.58 | 4.89 | |
Accounts Payable Turnover |
4.65 | 6.78 | 4.49 | 4.74 | |
Inventory Turnover |
3.37 | 3.86 | 3.27 | 3.57 | |
Average Days of Payables |
60.20 | 55.74 | 71.33 | 109.41 | |
Days of Inventory on Hand |
44.31 | 49.24 | 137.38 | 128.25 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
76.25% | 72.21% | 62.11% | 63.60% | |
Selling, General and Administrative Expense of Revenue |
158.58% | 161.66% | 131.06% | 125.79% | |
Share Based Compensation of Revenue |
16.92% | 17.76% | 14.50% | 14.41% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.48 | 0.42 | 0.57 | 0.71 | |
Depreciation/Fixed assets |
3.91 | 3.77 | 2.43 | 2.58 | |
Capex/Depreciation |
(0.06) | (0.06) | (0.12) | (0.12) | |
Revenue per Share |
9.39 | 11.09 | 14.74 | 16.57 | |
Operating CF per Share |
(12.90) | (12.59) | (16.00) | (20.89) | |
Capex per Share |
(0.55) | (0.58) | (1.19) | (1.18) | |
Capex to Sales |
0.06 | 0.05 | 0.08 | 0.07 | |
Net Profit Margin |
(287.90%) | (270.44%) | (191.32%) | (178.21%) |
Columns are period end dates